CClinicalTrials.gg
CompletedNCT03706352Updated Oct 16, 2018

Is Tunneling Effective in Preventing Failure of Epidural Analgesia? A Randomized Trial

An interventional study of tunneling epidural catheter in Epidural Catheter and Post Operative Pain, sponsored by King Hussein Cancer Center. Completed. Open to participants aged 20 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-16.

Sponsored by King Hussein Cancer Center · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled Apr 2015, registered Oct 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
20 Years to 85 Years
Sex
All
01

Study summary

This is a prospective randomized single blinded study in patients planned to undergo general anesthesia and epidural catheter insertion for pain control after abdominal, thoracic and orthopedic surgery.

Patients meeting participation criteria will be selected and enrolled sequentially.

The study recruitment will be carried out over one year with follow-up for each patient until either the catheter is dislodged or once decided that the patient is to be discontinued from the epidural pain control.

Read the detailed description

Study Population and Sample Size The study aims to enroll 200 adult patients planned to undergo general anesthesia and epidural catheter insertion. The study sample will be selected to fulfill the selection criteria.

Patients will be selected if they meet the following participation criteria:

Planned Procedures and Assessments Follow -up on dislodgments, adverse events, pain and pain relief assessment, standard practice Study Site All study conduction from start to end including procedures and assessments, data acquisition and analysis and final study conclusion report and any publications will be at King Hussein Cancer Center (KHCC).

Ethical Considerations The study will be submitted to the KHCC IRB for review. The study will not start before IRB approval is obtained.

All patients who provide consent to participation in the study will be randomized and enrolled.

Statistical Plan Descriptive statistics will be used to present the two groups baseline characteristics. Comparison between groups will be carried out using Chi-square test or t-test or Wilcox on rank test as appropriate. Comparison between groups while adjusting for other variables will be carried out using logistic regression. Odds ratios along with their 95% confidence intervals will be calculated.

02

Conditions studied

  • Epidural Catheter
  • Post Operative Pain

Browse trials for

Keywords

  • Cancer patients, Epidural analgesia, Postoperative pain, tunneling
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 200 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

King Hussein Cancer Center is the lead sponsor of 23 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patient is an adult, between 18-80 years old with normal mentation.

    • Patient has consented to general anesthesia and epidural catheter insertion for pain control after abdominal, thoracic and orthopedic surgery
    • Patient is able to understand and provide informed consent to participate in the study.

Exclusion criteria

Exclusion Criteria:

Patient is prone to coagulopathy.

  • Patient has infection at injection site.
  • Any Patient seen immediately before surgery-
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    tunneling group

    Epidural Catheter Insertion and fixation by subcutaneous tunneling procedure.

    Procedure: tunneling epidural catheter

  • Active comparator
    taping group

    Epidural Catheter Insertion and fixation by use of adhesive tape without tunneling.

    Procedure: tunneling epidural catheter

Interventions

  • Proceduretunneling epidural catheter

    The epidural needle was used to horizontally tunnel the catheter for a length of five centimeters on either side of the insertion point.

06

What researchers measure

Primary outcomes

  1. Difference in Rate of dislodgment between the two groups

    Descriptive statistics will be used to present the two groups baseline characteristics. Comparison between groups will be carried out using Chi-square test or t-test or Wilcox on rank test as appropriate. Comparison between groups while adjusting for other variables will be carried out using logistic regression. Odds ratios along with their 95% confidence intervals will be calculated.

    Time frame: 5 days

Secondary outcomes

  1. standard numerical pain score (NPS)

    use numerical pain score from zero no pain and 10 worst immaginable pain

    Time frame: 5 days

  2. Rate of adverse events

    infection, pain bleeding nerve damage, headache

    Time frame: 5 days

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03706352
Lead sponsor
King Hussein Cancer Center
Responsible party
Hussein Abu Khudair (chairman department of anesthesiology and pain management, King Hussein Cancer Center) — Principal investigator
First posted
Oct 16, 2018
Start date
Apr 14, 2015
Primary completion
Jul 13, 2017
Completion
Jul 13, 2017
Last update
Oct 16, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion